{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-132450","form_type":"8-K","ticker":"MDXG","cik":"0001376339","company_name":"MIMEDX GROUP, INC.","filed_at":"2023-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.636459+00:00","generated_at":"2026-06-16T03:06:00.102822+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"MiMedx Q1 net sales $71.7M (+21.7% YoY); net loss narrows to $5.0M; Adj. EBITDA $5.5M","bullets":["Net sales $71.7M in Q1 2023, up 21.7% from $58.9M in Q1 2022.","Net loss improved to $5.0M from $10.5M in prior year; Adjusted EBITDA of $5.5M.","CEO attributed growth to robust demand for new surgical products and accelerated growth in private physician offices.","Gross margin improved sequentially; operating expenses grew slower than sales.","Company also announced an upcoming Chief Financial Officer transition."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-132450","json":"https://secwatch.observer/filing/0001193125-23-132450.json","markdown":"https://secwatch.observer/filing/0001193125-23-132450.md","text":"https://secwatch.observer/filing/0001193125-23-132450.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/0001193125-23-132450-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/d79375d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T03:06:00.102822+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9dda4e0ca7706097b9903a27313b705b1507727c","claim":"MIMEDX GROUP, INC. reported first quarter 2023 results: revenue $71.7 million, net income net loss of $5.0 million.","evidence_excerpt":"announced operating and financial results for the first quarter 2023, which ended March 31, 2023, including net sales of $71.7 million, net loss of $5.0 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1376339/000119312523132450/0001193125-23-132450-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter 2023"},{"label":"Revenue","value":"$71.7 million"},{"label":"Net income","value":"net loss of $5.0 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}